EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of impaired fasting glucose with cardiometabolic multimorbidity: The Kailuan study

Zhihui Guo iD, Shouling Wu, Mengyi Zheng, Pengfei Xia, Qiuyun Li, Qing He, Zhenqiang Song

Journal of Diabetes Investigation · 2025

DOI: 10.1111/jdi.14316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Zhihui Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Multimorbidity, Blood Glucose, Fasting. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction We investigated the association between impaired fasting glucose (IFG) and cardiometabolic multimorbidity (CMM) in the Chinese population. Materials and Methods We included 119,368 participants, free of diabetes mellitus and cardiovascular disease, who participated in the health examination (2006, 2008, 2010) of the Kailuan Study. According to World Health Organization diagnostic criteria, participants were divided into normal fasting blood glucose (FBG) (1.25 (95% CI 1.13–1.37) for myocardial infarction, 1.16 (95% CI 1.07–1.25) for ischemic stroke and 1.06 (95% CI 0.88–1.27) for hemorrhagic stroke. Compared with normal FBG, HRs for risk of IFG for CMM were 2.73 (95% CI 2.48–3.02) in men and 3.86 (95% CI 2.92–5.09) in women. Conclusion IFG was a risk factor for CMM. The effect of IFG on diabetes mellitus was stronger than that on other cardiometabolic diseases. The effects of IFG for CMM differed by sex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MultimorbidityBlood GlucoseFastingHumansMaleFemaleMiddle AgedChinaAdultCardiovascular DiseasesDiabetes MellitusFollow-Up StudiesAgedRisk FactorsProportional Hazards ModelsGlucose Intolerance

Stichwörter der Autor:innen

Cardiometabolic multimorbidityCardiovascular diseasesImpaired fasting glucose

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Tianjin Medical University, Tianjin, China.
  • Department of Cardiology, Kailuan General Hospital, Tangshan, China.
  • Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Endocrinology and Metabolism, Kailuan General Hospital, Tangshan, China.
  • Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.

ORCID-Profile: Zhihui Guo

Zitieren

APA

Guo, Z., Wu, S., Zheng, M., Xia, P., Li, Q., He, Q., & Song, Z. (2025). Association of impaired fasting glucose with cardiometabolic multimorbidity: The Kailuan study. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14316

Vancouver

Guo Z, Wu S, Zheng M, Xia P, Li Q, He Q, et al. Association of impaired fasting glucose with cardiometabolic multimorbidity: The Kailuan study. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.14316

BibTeX
@article{Guo2025,
  author = {Guo, Zhihui and Wu, Shouling and Zheng, Mengyi and Xia, Pengfei and Li, Qiuyun and He, Qing and Song, Zhenqiang},
  title = {Association of impaired fasting glucose with cardiometabolic multimorbidity: The Kailuan study},
  journal = {Journal of Diabetes Investigation},
  year = {2025},
  doi = {10.1111/jdi.14316}
}
Kostenlos starten →